BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

737 related articles for article (PubMed ID: 16483878)

  • 1. Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome.
    Glueck CJ; Sieve L; Zhu B; Wang P
    Metabolism; 2006 Mar; 55(3):345-52. PubMed ID: 16483878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The factor V Leiden mutation, high factor VIII, and high plasminogen activator inhibitor activity: etiologies for sporadic miscarriage.
    Glueck CJ; Pranikoff J; Aregawi D; Haque M; Zhu B; Tracy T; Wang P
    Metabolism; 2005 Oct; 54(10):1345-9. PubMed ID: 16154434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of profound hyperinsulinism in polycystic ovary syndrome is associated with subtle elevations in the plasminogen activator inhibitor system.
    Sills ES; Drews CD; Perloe M; Tucker MJ; Kaplan CR; Palermo GD
    Gynecol Endocrinol; 2003 Jun; 17(3):231-7. PubMed ID: 12857431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome.
    Glueck CJ; Wang P; Fontaine RN; Sieve-Smith L; Tracy T; Moore SK
    Metabolism; 1999 Dec; 48(12):1589-95. PubMed ID: 10599993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 4G/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: an independent risk factor for serious pregnancy complications.
    Glueck CJ; Phillips H; Cameron D; Wang P; Fontaine RN; Moore SK; Sieve-Smith L; Tracy T
    Metabolism; 2000 Jul; 49(7):845-52. PubMed ID: 10909993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association of genetic polymorphisms in plasminogen activator inhibitor-1 gene and 5,10-methylenetetrahydrofolate reductase gene with recurrent early spontaneous abortion].
    Guan LX; Du XY; Wang JX; Gao L; Wang RL; Li HB; Wang SX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):330-3. PubMed ID: 15952129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome.
    Glueck CJ; Bornovali S; Pranikoff J; Goldenberg N; Dharashivkar S; Wang P
    Diabet Med; 2004 Aug; 21(8):829-36. PubMed ID: 15270785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin reduces abortion in pregnant women with polycystic ovary syndrome.
    Khattab S; Mohsen IA; Foutouh IA; Ramadan A; Moaz M; Al-Inany H
    Gynecol Endocrinol; 2006 Dec; 22(12):680-4. PubMed ID: 17162710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.
    Glueck CJ; Goldenberg N; Sieve L; Wang P
    Metabolism; 2008 Jul; 57(7):954-60. PubMed ID: 18555837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome.
    Glueck CJ; Wang P; Fontaine R; Tracy T; Sieve-Smith L
    Metabolism; 1999 Apr; 48(4):511-9. PubMed ID: 10206447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activator inhibitor 1 and miscarriage after metformin treatment and laparoscopic ovarian drilling in patients with polycystic ovary syndrome.
    Palomba S; Orio F; Falbo A; Russo T; Tolino A; Zullo F
    Fertil Steril; 2005 Sep; 84(3):761-5. PubMed ID: 16169420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuation of metformin reduces early pregnancy loss in obese Pakistani women with polycystic ovarian syndrome.
    Nawaz FH; Rizvi J
    Gynecol Obstet Invest; 2010; 69(3):184-9. PubMed ID: 20029224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
    Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
    Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G polymorphism and metabolic/proinflammatory factors in polycystic ovary syndrome.
    Sales MF; Sóter MO; Candido AL; Fernandes AP; Oliveira FR; Ferreira AC; Sousa MO; Ferreira CN; Gomes KB
    Gynecol Endocrinol; 2013 Oct; 29(10):936-9. PubMed ID: 23898913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enoxaparin-metformin and enoxaparin alone may safely reduce pregnancy loss.
    Ramidi G; Khan N; Glueck CJ; Wang P; Goldenberg N
    Transl Res; 2009 Jan; 153(1):33-43. PubMed ID: 19100956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reproductive problems in women with PCOS, the impact of PAI-1 carriers of 4G PAI-1 polymorphism and BMI].
    Komsa-Penkova R; Golemanov G; Georgieva G; Popovski K; Slavov N; Ivanov P; Kovacheva K; Atanasova M; Blajev A
    Akush Ginekol (Sofiia); 2014; 53(6):15-21. PubMed ID: 25672133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels.
    Diamanti-Kandarakis E; Palioniko G; Alexandraki K; Bergiele A; Koutsouba T; Bartzis M
    Eur J Endocrinol; 2004 Jun; 150(6):793-8. PubMed ID: 15191349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of gender and genetic variance in plasminogen activator inhibitor-1 secretion from human adipose tissue.
    van Harmelen V; Wahrenberg H; Eriksson P; Arner P
    Thromb Haemost; 2000 Feb; 83(2):304-8. PubMed ID: 10739390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study.
    Glueck CJ; Phillips H; Cameron D; Sieve-Smith L; Wang P
    Fertil Steril; 2001 Jan; 75(1):46-52. PubMed ID: 11163815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the plasminogen activator inhibitor-1 gene a candidate gene predisposing to hypertension? Results from a population-based study in Spain.
    Martínez-Calatrava MJ; González-Sánchez JL; Zabena C; Martínez-Larrad MT; Luque-Otero M; Serrano-Ríos M
    J Hypertens; 2007 Apr; 25(4):773-7. PubMed ID: 17351368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.